GR3024690T3 - Calcium channel blocking polypeptides from filistata hibernalis. - Google Patents

Calcium channel blocking polypeptides from filistata hibernalis.

Info

Publication number
GR3024690T3
GR3024690T3 GR970402338T GR970402338T GR3024690T3 GR 3024690 T3 GR3024690 T3 GR 3024690T3 GR 970402338 T GR970402338 T GR 970402338T GR 970402338 T GR970402338 T GR 970402338T GR 3024690 T3 GR3024690 T3 GR 3024690T3
Authority
GR
Greece
Prior art keywords
pct
calcium channel
channel blocking
date
filistata hibernalis
Prior art date
Application number
GR970402338T
Other languages
English (en)
Inventor
Deane M Ii Nason
Robert T Ronau
Nicholas Saccomano
Robert A Volkmann
Steven D Heck
Original Assignee
Pfizer
Nps Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Nps Pharma Inc filed Critical Pfizer
Publication of GR3024690T3 publication Critical patent/GR3024690T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GR970402338T 1992-05-21 1997-09-10 Calcium channel blocking polypeptides from filistata hibernalis. GR3024690T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88707392A 1992-05-21 1992-05-21
PCT/US1993/003921 WO1993023428A1 (en) 1992-05-21 1993-04-30 Calcium channel blocking polypeptides from filistata hibernalis

Publications (1)

Publication Number Publication Date
GR3024690T3 true GR3024690T3 (en) 1997-12-31

Family

ID=25390404

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970402338T GR3024690T3 (en) 1992-05-21 1997-09-10 Calcium channel blocking polypeptides from filistata hibernalis.

Country Status (26)

Country Link
US (1) US5804554A (el)
EP (1) EP0672056B1 (el)
JP (1) JP2572715B2 (el)
KR (1) KR950701647A (el)
CN (1) CN1034123C (el)
AT (1) ATE155488T1 (el)
AU (1) AU668170B2 (el)
BR (1) BR9306388A (el)
CA (1) CA2134889C (el)
CZ (1) CZ284794A3 (el)
DE (1) DE69312320T2 (el)
DK (1) DK0672056T3 (el)
EG (1) EG20275A (el)
ES (1) ES2105261T3 (el)
FI (1) FI932284A (el)
GR (1) GR3024690T3 (el)
HU (1) HUT64570A (el)
IL (1) IL105694A (el)
MX (1) MX9302925A (el)
MY (1) MY108890A (el)
NO (1) NO944417L (el)
NZ (1) NZ252452A (el)
RU (1) RU2106358C1 (el)
TW (1) TW336938B (el)
WO (1) WO1993023428A1 (el)
ZA (1) ZA933493B (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5461032A (en) * 1991-03-01 1995-10-24 Fmc Corporation Insecticidally effective peptides
IL104419A0 (en) * 1992-01-24 1993-05-13 Fmc Corp Insecticidally effective peptides
US5457178A (en) * 1993-07-07 1995-10-10 Fmc Corporation Insecticidally effective spider toxin
US5756459A (en) * 1995-06-07 1998-05-26 Fmc Corporation Insecticidally effective peptides isolatable from phidippus spider venom
CO5180581A1 (es) * 1999-09-30 2002-07-30 Pfizer Prod Inc Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5239059A (en) * 1991-05-10 1993-08-24 The Children's Hospital Of Philadelphia Ion-channel forming peptides

Also Published As

Publication number Publication date
CA2134889C (en) 1998-03-31
TW336938B (en) 1998-07-21
EG20275A (en) 1998-05-31
ZA933493B (en) 1994-11-21
ES2105261T3 (es) 1997-10-16
DE69312320D1 (de) 1997-08-21
CZ284794A3 (en) 1995-08-16
NO944417D0 (no) 1994-11-18
CN1034123C (zh) 1997-02-26
MY108890A (en) 1996-11-30
IL105694A (en) 1998-02-22
EP0672056B1 (en) 1997-07-16
ATE155488T1 (de) 1997-08-15
NO944417L (no) 1994-11-18
FI932284A0 (fi) 1993-05-19
RU2106358C1 (ru) 1998-03-10
CN1080931A (zh) 1994-01-19
FI932284A (fi) 1993-11-22
US5804554A (en) 1998-09-08
KR950701647A (ko) 1995-04-28
NZ252452A (en) 1996-07-26
JPH07503735A (ja) 1995-04-20
HU9301476D0 (en) 1993-09-28
DE69312320T2 (de) 1997-10-30
BR9306388A (pt) 1998-09-15
CA2134889A1 (en) 1993-11-25
MX9302925A (es) 1993-11-01
AU668170B2 (en) 1996-04-26
AU4117893A (en) 1993-12-13
DK0672056T3 (da) 1997-12-08
RU94046023A (ru) 1996-10-10
IL105694A0 (en) 1993-09-22
JP2572715B2 (ja) 1997-01-16
HUT64570A (en) 1994-01-28
WO1993023428A1 (en) 1993-11-25
EP0672056A1 (en) 1995-09-20

Similar Documents

Publication Publication Date Title
GR3024637T3 (en) Calcium channel blocking polypeptide from agelenopsis aperta.
GR3024690T3 (en) Calcium channel blocking polypeptides from filistata hibernalis.
TW272196B (el)
CA2146367A1 (en) Calcium channel blocking polypeptides from heteropoda venatoria